Project
Illumina Body Map 2
Navigation
Downloads
Results for TAL1
Z-value: 3.22
Motif logo
Transcription factors associated with TAL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TAL1
|
ENSG00000162367.7 | TAL bHLH transcription factor 1, erythroid differentiation factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TAL1 | hg19_v2_chr1_-_47697387_47697457 | 0.69 | 1.1e-05 | Click! |
Activity profile of TAL1 motif
Sorted Z-values of TAL1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_106781017 | 16.60 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
| chr2_-_89247338 | 13.54 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr22_+_22681656 | 13.39 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr14_-_106539557 | 13.27 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr22_+_22730353 | 12.91 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
| chr14_-_106758101 | 11.35 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
| chr22_+_23029188 | 10.80 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr22_+_23040274 | 10.64 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr14_-_106967788 | 10.48 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr14_-_106406090 | 10.39 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr22_+_23165153 | 10.36 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr14_-_106494587 | 10.31 |
ENST00000390597.2
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
| chr14_-_106312010 | 10.17 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
| chr14_-_106878083 | 10.04 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr14_-_106805716 | 10.03 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
| chr22_+_23222886 | 9.95 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
| chr14_-_106114739 | 9.83 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
| chr14_-_106478603 | 9.63 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
| chr14_-_106322288 | 9.56 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr14_-_106518922 | 9.37 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr22_+_23134974 | 9.07 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr14_-_107219365 | 9.01 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr16_+_23847339 | 8.69 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr14_-_107078851 | 8.66 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr7_+_142326335 | 8.49 |
ENST00000390393.3
|
TRBV19
|
T cell receptor beta variable 19 |
| chr14_-_107179265 | 8.27 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
| chr14_-_107131560 | 7.94 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
| chr16_+_32859034 | 7.53 |
ENST00000567458.2
ENST00000560724.1 |
IGHV2OR16-5
|
immunoglobulin heavy variable 2/OR16-5 (non-functional) |
| chr22_+_23077065 | 7.48 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr15_-_20170354 | 7.48 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr21_-_46330545 | 7.39 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr22_+_22453093 | 7.37 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
| chr2_+_89999259 | 7.29 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr2_+_89952792 | 7.21 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr2_-_89310012 | 7.21 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr14_-_107095662 | 7.15 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
| chr14_-_106791536 | 7.01 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
| chr7_+_142020496 | 6.90 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
| chr14_+_22314715 | 6.86 |
ENST00000390434.3
|
TRAV8-2
|
T cell receptor alpha variable 8-2 |
| chr22_+_23154239 | 6.76 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr14_-_106926724 | 6.73 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr22_+_23063100 | 6.69 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr14_-_106453155 | 6.66 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr2_+_90153696 | 6.62 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr2_-_89568263 | 6.62 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr7_-_38339890 | 6.55 |
ENST00000390341.2
|
TRGV10
|
T cell receptor gamma variable 10 (non-functional) |
| chr16_+_32077386 | 6.50 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr7_-_142181009 | 6.48 |
ENST00000390368.2
|
TRBV6-5
|
T cell receptor beta variable 6-5 |
| chr6_-_24911195 | 6.43 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
| chr7_-_142162390 | 6.38 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
| chr16_+_23847355 | 6.37 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
| chr16_+_33629600 | 6.36 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
| chr6_-_31560729 | 6.27 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
| chr15_-_22473353 | 6.24 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
| chr14_+_22362613 | 6.23 |
ENST00000390438.2
|
TRAV8-4
|
T cell receptor alpha variable 8-4 |
| chr22_+_23101182 | 6.22 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr12_+_6554021 | 6.21 |
ENST00000266557.3
|
CD27
|
CD27 molecule |
| chr22_+_22764088 | 6.18 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr4_+_74718906 | 6.04 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
| chr2_+_90139056 | 6.03 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr13_+_108922228 | 6.01 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
| chr2_-_89417335 | 5.98 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr7_-_142198049 | 5.96 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
| chr16_+_23847267 | 5.95 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr2_-_235405168 | 5.94 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr7_-_142247606 | 5.88 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
| chr6_+_6588316 | 5.86 |
ENST00000379953.2
|
LY86
|
lymphocyte antigen 86 |
| chr2_-_89513402 | 5.80 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr7_-_38394118 | 5.77 |
ENST00000390345.2
|
TRGV4
|
T cell receptor gamma variable 4 |
| chr2_-_158345462 | 5.74 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr2_+_89184868 | 5.73 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr7_-_142149390 | 5.72 |
ENST00000390372.3
|
TRBV5-5
|
T cell receptor beta variable 5-5 |
| chr17_-_39258461 | 5.69 |
ENST00000440582.1
|
KRTAP4-16P
|
keratin associated protein 4-16, pseudogene |
| chr16_+_28943260 | 5.66 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
| chr7_-_142240014 | 5.61 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
| chr22_+_23089870 | 5.61 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr21_+_10862622 | 5.61 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr22_+_22723969 | 5.60 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
| chr14_-_106552755 | 5.60 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
| chr14_+_22446680 | 5.56 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
| chr7_+_142428476 | 5.55 |
ENST00000390400.2
|
TRBV28
|
T cell receptor beta variable 28 |
| chr14_-_106471723 | 5.50 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr22_+_22385332 | 5.48 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
| chr22_+_23010756 | 5.31 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
| chr2_-_89597542 | 5.30 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
| chr11_-_117698787 | 5.29 |
ENST00000260287.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr14_-_106725723 | 5.29 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr17_-_79623597 | 5.29 |
ENST00000574024.1
ENST00000331056.5 |
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma |
| chr19_-_50868882 | 5.29 |
ENST00000598915.1
|
NAPSA
|
napsin A aspartic peptidase |
| chr22_-_42322795 | 5.28 |
ENST00000291232.3
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C |
| chr2_-_87017985 | 5.26 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
| chr20_+_3776371 | 5.26 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
| chr14_-_107199464 | 5.19 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
| chr14_-_106586656 | 5.18 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
| chr15_-_22448819 | 5.15 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr8_+_56014949 | 5.14 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
| chr7_-_38398721 | 5.13 |
ENST00000390346.2
|
TRGV3
|
T cell receptor gamma variable 3 |
| chr14_+_22433675 | 5.05 |
ENST00000390442.3
|
TRAV12-3
|
T cell receptor alpha variable 12-3 |
| chr14_+_22386325 | 5.03 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr2_-_87018784 | 5.02 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
| chr14_+_98602380 | 5.02 |
ENST00000557072.1
|
RP11-61O1.2
|
RP11-61O1.2 |
| chr22_+_22930626 | 5.00 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr16_-_33647696 | 4.99 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr22_+_22516550 | 4.97 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
| chr11_+_118175132 | 4.96 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
| chr14_-_107013465 | 4.95 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
| chr22_+_23247030 | 4.93 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr14_-_94856987 | 4.92 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr7_-_150497621 | 4.90 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
| chr4_-_165305086 | 4.88 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
| chr1_+_117297007 | 4.87 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr7_-_38403077 | 4.83 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
| chr7_+_142000747 | 4.82 |
ENST00000455382.2
|
TRBV2
|
T cell receptor beta variable 2 |
| chr14_-_106816253 | 4.81 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
| chr2_+_89923550 | 4.76 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chr3_-_112218378 | 4.76 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
| chr14_-_106642049 | 4.72 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr14_-_106209368 | 4.71 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr2_-_89278535 | 4.69 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr2_+_89998789 | 4.67 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr14_+_22771851 | 4.67 |
ENST00000390466.1
|
TRAV39
|
T cell receptor alpha variable 39 |
| chr22_+_23248512 | 4.65 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr14_-_107170409 | 4.62 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
| chr22_+_23264766 | 4.62 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr14_-_94856951 | 4.60 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr7_+_142045246 | 4.57 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
| chr7_-_38370536 | 4.55 |
ENST00000390343.2
|
TRGV8
|
T cell receptor gamma variable 8 |
| chr14_-_106830057 | 4.55 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr2_+_204732666 | 4.55 |
ENST00000295854.6
ENST00000472206.1 |
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4 |
| chr14_-_106866934 | 4.52 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
| chr17_+_6900201 | 4.51 |
ENST00000480801.1
|
ALOX12
|
arachidonate 12-lipoxygenase |
| chr7_+_142423143 | 4.49 |
ENST00000390399.3
|
TRBV27
|
T cell receptor beta variable 27 |
| chr14_-_106573756 | 4.47 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
| chr2_+_204732487 | 4.46 |
ENST00000302823.3
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4 |
| chr19_+_55085248 | 4.42 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| chr22_+_23161491 | 4.36 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
| chr4_-_74847800 | 4.35 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
| chr17_-_38721711 | 4.32 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
| chr2_-_89157161 | 4.32 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
| chr2_-_158345341 | 4.31 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
| chr14_-_107114267 | 4.30 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr6_-_149806105 | 4.27 |
ENST00000389942.5
ENST00000416573.2 ENST00000542614.1 ENST00000409806.3 |
ZC3H12D
|
zinc finger CCCH-type containing 12D |
| chr22_+_22697537 | 4.22 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
| chr7_+_150026938 | 4.21 |
ENST00000343855.4
|
ZBED6CL
|
ZBED6 C-terminal like |
| chr2_-_87017948 | 4.21 |
ENST00000409781.1
|
CD8A
|
CD8a molecule |
| chrX_-_70331298 | 4.20 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
| chr14_-_94857004 | 4.19 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chrX_+_118892545 | 4.17 |
ENST00000343905.3
|
SOWAHD
|
sosondowah ankyrin repeat domain family member D |
| chr1_+_161677034 | 4.11 |
ENST00000349527.4
ENST00000309691.6 ENST00000294796.4 ENST00000367953.3 ENST00000367950.1 |
FCRLA
|
Fc receptor-like A |
| chr22_+_23229960 | 4.09 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr17_-_73839792 | 4.05 |
ENST00000590762.1
|
UNC13D
|
unc-13 homolog D (C. elegans) |
| chr2_+_90211643 | 4.04 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr22_+_22550113 | 4.03 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr7_+_150497569 | 4.03 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
| chr7_+_150497491 | 4.02 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
| chr1_-_92951607 | 4.01 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
| chr14_+_22392209 | 3.99 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
| chr1_+_27668505 | 3.97 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
| chr1_+_207627575 | 3.96 |
ENST00000367058.3
ENST00000367057.3 ENST00000367059.3 |
CR2
|
complement component (3d/Epstein Barr virus) receptor 2 |
| chr1_-_169555779 | 3.95 |
ENST00000367797.3
ENST00000367796.3 |
F5
|
coagulation factor V (proaccelerin, labile factor) |
| chr2_+_114163945 | 3.95 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr21_-_46334186 | 3.94 |
ENST00000522931.1
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr15_+_81489213 | 3.93 |
ENST00000559383.1
ENST00000394660.2 |
IL16
|
interleukin 16 |
| chrX_+_78426469 | 3.89 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
| chr14_+_22320634 | 3.87 |
ENST00000390435.1
|
TRAV8-3
|
T cell receptor alpha variable 8-3 |
| chr2_-_89459813 | 3.87 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr11_+_128634589 | 3.81 |
ENST00000281428.8
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
| chr7_+_142028105 | 3.78 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
| chr16_+_30485267 | 3.78 |
ENST00000569725.1
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr17_-_80275466 | 3.78 |
ENST00000312648.3
|
CD7
|
CD7 molecule |
| chr14_-_107211459 | 3.77 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
| chr15_-_31521567 | 3.77 |
ENST00000560812.1
ENST00000559853.1 ENST00000558109.1 |
RP11-16E12.2
|
RP11-16E12.2 |
| chr1_-_167487758 | 3.76 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
| chr20_-_62493217 | 3.74 |
ENST00000601296.1
|
C20ORF135
|
C20ORF135 |
| chr1_+_200842083 | 3.71 |
ENST00000304244.2
|
GPR25
|
G protein-coupled receptor 25 |
| chr2_+_98330009 | 3.69 |
ENST00000264972.5
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa |
| chr22_+_22712087 | 3.67 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
| chr3_+_32433154 | 3.66 |
ENST00000334983.5
ENST00000349718.4 |
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7 |
| chr14_-_107049312 | 3.66 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr21_-_46340807 | 3.65 |
ENST00000397846.3
ENST00000524251.1 ENST00000522688.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr2_+_90198535 | 3.64 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr14_-_107035208 | 3.64 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
| chr16_-_88772670 | 3.63 |
ENST00000562544.1
|
RNF166
|
ring finger protein 166 |
| chr12_+_6898674 | 3.60 |
ENST00000541982.1
ENST00000539492.1 |
CD4
|
CD4 molecule |
| chr22_+_24823517 | 3.59 |
ENST00000496258.1
ENST00000337539.7 |
ADORA2A
|
adenosine A2a receptor |
| chr5_+_49962772 | 3.59 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr17_+_34538310 | 3.57 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
| chr7_-_142176790 | 3.57 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
| chr14_-_106331652 | 3.56 |
ENST00000390565.1
|
IGHJ1
|
immunoglobulin heavy joining 1 |
| chr3_+_45982401 | 3.56 |
ENST00000438735.1
|
CXCR6
|
chemokine (C-X-C motif) receptor 6 |
| chr19_-_54850417 | 3.55 |
ENST00000291759.4
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 |
| chr5_-_156569850 | 3.53 |
ENST00000524219.1
|
HAVCR2
|
hepatitis A virus cellular receptor 2 |
| chr1_-_202130702 | 3.53 |
ENST00000309017.3
ENST00000477554.1 ENST00000492451.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr11_-_117695449 | 3.52 |
ENST00000292079.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr1_-_161039647 | 3.51 |
ENST00000368013.3
|
ARHGAP30
|
Rho GTPase activating protein 30 |
| chr2_+_89901292 | 3.51 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr1_-_160832490 | 3.50 |
ENST00000322302.7
ENST00000368033.3 |
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
| chr11_+_71846748 | 3.50 |
ENST00000445078.2
|
FOLR3
|
folate receptor 3 (gamma) |
| chr19_+_1065922 | 3.50 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr7_-_38389573 | 3.49 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
Network of associatons between targets according to the STRING database.
First level regulatory network of TAL1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 21.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 4.3 | 4.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 3.0 | 15.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 2.9 | 507.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 2.9 | 14.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 2.4 | 2.4 | GO:0043318 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 2.3 | 11.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 2.2 | 2.2 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 2.2 | 8.7 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 2.1 | 32.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 2.1 | 6.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 2.0 | 4.0 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 2.0 | 5.9 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 1.9 | 5.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 1.8 | 9.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.8 | 5.5 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 1.8 | 5.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 1.8 | 3.5 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.8 | 5.3 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.7 | 8.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.7 | 6.9 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 1.7 | 8.6 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 1.7 | 6.6 | GO:0002432 | granuloma formation(GO:0002432) |
| 1.5 | 9.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 1.4 | 4.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.4 | 1.4 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 1.4 | 1.4 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 1.4 | 4.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.3 | 4.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 1.3 | 5.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 1.3 | 4.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.3 | 7.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.3 | 2.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.3 | 7.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.3 | 3.8 | GO:0040010 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 1.2 | 3.6 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 1.2 | 9.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.1 | 6.8 | GO:0032571 | response to vitamin K(GO:0032571) |
| 1.1 | 4.5 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 1.1 | 2.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
| 1.1 | 3.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 1.1 | 7.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 1.1 | 9.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.1 | 4.3 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 1.1 | 6.3 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
| 1.0 | 4.2 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 1.0 | 2.0 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 1.0 | 5.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.0 | 10.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.0 | 7.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.0 | 2.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 1.0 | 1.0 | GO:0044060 | regulation of endocrine process(GO:0044060) |
| 1.0 | 2.9 | GO:0033214 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 1.0 | 20.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.9 | 6.6 | GO:0043316 | cytotoxic T cell degranulation(GO:0043316) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.9 | 3.7 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.9 | 196.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.9 | 5.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.9 | 5.3 | GO:0043366 | beta selection(GO:0043366) |
| 0.9 | 1.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.8 | 4.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.8 | 4.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 2.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.8 | 5.6 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.8 | 4.8 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.8 | 2.3 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.8 | 2.3 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 | 3.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.7 | 10.4 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.7 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.7 | 3.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.7 | 2.2 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.7 | 4.4 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.7 | 2.2 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.7 | 2.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.7 | 2.9 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.7 | 2.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.7 | 2.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.7 | 7.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.7 | 6.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.7 | 0.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
| 0.7 | 9.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.7 | 0.7 | GO:0045992 | negative regulation of embryonic development(GO:0045992) regulation of endodermal cell differentiation(GO:1903224) negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.7 | 2.7 | GO:0034255 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.7 | 2.0 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.7 | 0.7 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.7 | 2.0 | GO:0070054 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.7 | 4.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.7 | 1.3 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.7 | 1.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.7 | 1.3 | GO:0002434 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 0.7 | 4.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.7 | 1.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.6 | 1.3 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.6 | 1.9 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.6 | 2.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.6 | 2.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.6 | 1.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.6 | 1.9 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.6 | 2.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.6 | 1.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) pathway-restricted SMAD protein phosphorylation(GO:0060389) |
| 0.6 | 3.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.6 | 0.6 | GO:2000451 | positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
| 0.6 | 3.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 | 1.8 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.6 | 4.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.6 | 4.0 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.6 | 5.8 | GO:2001179 | regulation of interleukin-10 secretion(GO:2001179) |
| 0.6 | 0.6 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
| 0.6 | 4.0 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.6 | 0.6 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.6 | 11.9 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.6 | 4.0 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.6 | 3.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.6 | 6.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.5 | 3.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.5 | 2.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 | 2.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.5 | 1.6 | GO:2001226 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
| 0.5 | 14.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.5 | 0.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.5 | 6.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.5 | 4.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 1.6 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.5 | 3.1 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.5 | 3.1 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.5 | 1.0 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.5 | 5.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.5 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.5 | 0.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.5 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
| 0.5 | 2.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.5 | 2.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.5 | 1.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.5 | 2.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.5 | 2.0 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.5 | 6.0 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.5 | 1.5 | GO:0060490 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.5 | 1.4 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.5 | 0.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.5 | 1.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.5 | 2.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.5 | 2.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.5 | 1.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.5 | 3.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.5 | 3.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.5 | 1.4 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.5 | 1.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 | 3.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.5 | 0.5 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.5 | 0.9 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.5 | 34.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.5 | 4.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 10.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 | 1.8 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.5 | 4.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.5 | 1.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.5 | 0.9 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.5 | 1.4 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.5 | 0.5 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.5 | 1.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.4 | 0.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.4 | 1.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.4 | 2.7 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.4 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.4 | 5.4 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.4 | 2.7 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 | 2.7 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.4 | 7.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.4 | 0.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
| 0.4 | 2.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.4 | 1.3 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.4 | 5.1 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
| 0.4 | 1.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.4 | 2.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.4 | 3.4 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.4 | 1.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.4 | 0.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.4 | 2.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.4 | 1.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 | 3.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 | 4.1 | GO:0001554 | luteolysis(GO:0001554) |
| 0.4 | 0.4 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.4 | 3.6 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.4 | 4.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.4 | 20.4 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.4 | 5.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.4 | 0.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 2.0 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 | 3.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.4 | 1.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.4 | 7.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.4 | 2.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.4 | 1.2 | GO:0002352 | B cell selection(GO:0002339) B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.4 | 1.2 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
| 0.4 | 1.2 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.4 | 131.7 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.4 | 7.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
| 0.4 | 1.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.4 | 1.1 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.4 | 0.4 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.4 | 2.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.4 | 2.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 | 0.7 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.4 | 5.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 0.4 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 1.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.4 | 1.8 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.4 | 3.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.4 | 1.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 | 1.8 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.4 | 1.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.4 | 1.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 | 0.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.3 | 2.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 0.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 3.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.3 | 1.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.3 | 0.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.3 | 6.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.3 | 0.7 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 | 3.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.3 | 1.3 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.3 | 3.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.3 | 19.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.3 | 2.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.3 | 1.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.3 | 3.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.3 | 4.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 | 1.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 | 10.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.3 | 33.5 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.3 | 1.3 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.3 | 1.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.3 | 4.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.3 | 0.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.3 | 1.6 | GO:1903282 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.3 | 1.3 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.3 | 0.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.3 | 0.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.3 | 1.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.3 | 1.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.3 | 1.5 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.3 | 1.2 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 26.0 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.3 | 0.3 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 0.3 | 0.3 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.3 | 2.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.3 | 0.9 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.3 | 0.6 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.3 | 2.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 3.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.3 | 2.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.3 | 1.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.3 | 0.9 | GO:1903464 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.3 | 0.9 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.3 | 1.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.3 | 1.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.3 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 1.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.3 | 2.0 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.3 | 0.9 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 | 3.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.3 | 0.8 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.3 | 0.8 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.3 | 2.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.3 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.3 | 4.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.3 | 2.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 | 1.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 | 1.3 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.3 | 2.7 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 | 2.4 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.3 | 0.5 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 | 2.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 2.4 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.3 | 0.8 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.3 | 2.6 | GO:0008228 | opsonization(GO:0008228) |
| 0.3 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.3 | 0.8 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
| 0.3 | 0.8 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.3 | 1.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.3 | 0.3 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.3 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 | 0.8 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.3 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 | 3.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 1.8 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 | 3.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 | 1.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 | 2.3 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.3 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 | 2.5 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.3 | 1.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.3 | 1.3 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.3 | 2.5 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.2 | 1.2 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.2 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 | 0.5 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.2 | 0.5 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.2 | 1.9 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 1.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.2 | 0.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 | 0.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.2 | 2.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 1.0 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.2 | 0.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.2 | 2.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 2.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 | 1.9 | GO:0090197 | regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.2 | 0.7 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.2 | 4.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.2 | 0.7 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 6.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.2 | 0.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.2 | 0.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.2 | 1.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 1.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 6.9 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.2 | 4.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 5.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.2 | 0.9 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 0.5 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.2 | 0.7 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.2 | 1.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.2 | 3.0 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 0.5 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.2 | 4.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 1.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 | 1.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 1.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 12.7 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.2 | 1.1 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.2 | 1.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 0.4 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.2 | 0.9 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.2 | 0.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 | 0.9 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.2 | 0.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 | 1.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.2 | 2.8 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.2 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
| 0.2 | 2.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 | 0.2 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.2 | 0.9 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 0.6 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 | 0.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.2 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 0.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.2 | 5.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 1.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 | 0.2 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.2 | 2.1 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.2 | 0.8 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 2.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.2 | 0.4 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.2 | 1.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.2 | 0.6 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.2 | 1.8 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.2 | 0.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.2 | 0.4 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
| 0.2 | 0.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 | 2.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 6.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.2 | 3.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 1.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.2 | 2.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 2.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.2 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 0.2 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
| 0.2 | 1.3 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.2 | 1.3 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.2 | 0.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 | 1.3 | GO:2000771 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) negative regulation of dendritic spine maintenance(GO:1902951) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.2 | 0.9 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.2 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.2 | 0.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
| 0.2 | 0.4 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.2 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 | 0.4 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 0.2 | 3.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 4.7 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 0.7 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.2 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.2 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.2 | 2.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 3.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.2 | 1.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 | 0.5 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
| 0.2 | 0.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.2 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.2 | 5.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.5 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.2 | 0.5 | GO:0009624 | response to nematode(GO:0009624) |
| 0.2 | 0.7 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.2 | 2.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
| 0.2 | 2.3 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 | 2.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 0.7 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 0.5 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.2 | 1.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.2 | 1.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
| 0.2 | 0.6 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.2 | 0.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 | 1.4 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.2 | 4.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 | 0.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.2 | 0.5 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 | 0.2 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.2 | 2.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.2 | 0.9 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 1.4 | GO:1902748 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.2 | 1.6 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 | 0.5 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.2 | 0.8 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.2 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.2 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 0.6 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.2 | 0.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 0.4 | GO:0050894 | determination of affect(GO:0050894) |
| 0.1 | 0.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 1.3 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 | 1.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 1.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 0.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 1.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 | 0.7 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.1 | 0.3 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 1.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.7 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 2.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 4.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.6 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 1.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.1 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 | 0.8 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.1 | 2.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 1.7 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.1 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 1.9 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.1 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.1 | 0.3 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 | 1.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 0.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.1 | 0.3 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.1 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 0.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 3.9 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.7 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.1 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.1 | 1.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 | 3.2 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.1 | 12.2 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.1 | 1.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.1 | 1.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.6 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 3.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 0.3 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.1 | 0.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 | 1.9 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.5 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 1.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 3.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 1.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.1 | 1.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 1.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 3.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 4.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.4 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.1 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.4 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.1 | 1.3 | GO:0070231 | T cell apoptotic process(GO:0070231) |
| 0.1 | 0.4 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.1 | 3.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.7 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.4 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.1 | 0.7 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 1.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 | 1.2 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 1.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.1 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 | 1.0 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 1.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 1.1 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 6.0 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 0.6 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 2.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 | 1.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 | 0.3 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 | 0.3 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 0.1 | 0.2 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.1 | 1.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 | 0.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 | 0.2 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.1 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 0.1 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.1 | 0.2 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.1 | 1.0 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 1.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.1 | 0.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.1 | 1.5 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 | 2.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.1 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 0.2 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) |
| 0.1 | 1.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 0.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 1.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 | 0.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 1.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 1.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 2.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.1 | 0.8 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
| 0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.4 | GO:0071505 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) |
| 0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 3.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.1 | 1.9 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 0.9 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
| 0.1 | 0.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 0.6 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.5 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 0.1 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.1 | 2.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 2.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.3 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 | 3.2 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 5.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 | 1.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 0.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.1 | 1.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 1.2 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
| 0.1 | 1.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 1.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 | 4.3 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
| 0.1 | 0.5 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 4.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 1.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.1 | 0.8 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 | 2.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 3.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 0.1 | 2.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 2.5 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 53.2 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.3 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
| 0.1 | 1.6 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 2.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.1 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 3.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 | 3.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 1.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.3 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 0.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.1 | 0.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.1 | 0.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
| 0.1 | 0.3 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
| 0.1 | 0.4 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 0.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 | 0.5 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 0.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 | 0.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 3.0 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.1 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 | 0.3 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 1.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 0.1 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 | 0.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.1 | 0.3 | GO:0051648 | vesicle localization(GO:0051648) |
| 0.1 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 1.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 1.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.3 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.1 | 0.9 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 | 0.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 0.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.1 | 0.6 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.1 | 0.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.1 | 0.9 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.1 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 1.6 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 0.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.1 | 0.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 | 0.2 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.1 | 0.3 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
| 0.1 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.1 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 0.7 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 | 1.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.9 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.1 | 0.2 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.1 | 0.1 | GO:0050818 | regulation of coagulation(GO:0050818) |
| 0.1 | 2.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.6 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 0.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 2.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 | 1.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 0.5 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 0.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
| 0.1 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.1 | 0.3 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 | 0.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 | 1.4 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 | 2.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
| 0.1 | 1.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.1 | 8.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.1 | 0.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 0.4 | GO:2001236 | regulation of extrinsic apoptotic signaling pathway(GO:2001236) |
| 0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.2 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 | 0.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.1 | GO:0032213 | regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) |
| 0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 1.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 0.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.4 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 | 0.5 | GO:0060965 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 | 0.2 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.1 | 0.4 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.4 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 | 0.7 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 1.5 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.1 | 0.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.1 | 0.4 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 0.2 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 | 0.7 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 0.1 | 2.5 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.1 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
| 0.1 | 0.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.3 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.1 | 1.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 1.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 0.2 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 | 0.6 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.1 | 0.3 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.1 | 0.8 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.1 | 0.2 | GO:0051152 | regulation of smooth muscle cell differentiation(GO:0051150) positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.1 | 0.4 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 | 0.2 | GO:0035646 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.7 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 0.3 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.1 | 0.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.1 | 1.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.3 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 0.6 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.2 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.1 | GO:1903422 | regulation of synaptic activity(GO:0060025) negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 0.2 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.1 | 1.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 0.2 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 7.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 0.6 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 6.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 1.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.1 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.1 | 0.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.0 | 0.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.0 | 1.1 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
| 0.0 | 0.3 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
| 0.0 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.0 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.0 | 0.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.0 | 1.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.0 | 0.1 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.0 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 | 0.2 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.0 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.0 | 1.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.0 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.0 | 0.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.0 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.0 | 0.5 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.0 | 0.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
| 0.0 | 0.2 | GO:0036508 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 2.0 | GO:0070671 | response to interleukin-12(GO:0070671) |
| 0.0 | 0.2 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.0 | 0.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.0 | 0.1 | GO:1904502 | sphinganine metabolic process(GO:0006667) lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 1.0 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 | 0.3 | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation(GO:0050730) |
| 0.0 | 0.1 | GO:0044782 | cilium organization(GO:0044782) |
| 0.0 | 0.3 | GO:0033504 | floor plate development(GO:0033504) |
| 0.0 | 0.2 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.0 | 0.0 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.0 | 4.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.2 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.0 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.0 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.0 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 | 0.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.0 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.0 | 0.7 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.0 | 0.5 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) positive regulation of biomineral tissue development(GO:0070169) |
| 0.0 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.0 | 1.6 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 0.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.2 | GO:1902116 | negative regulation of centriole replication(GO:0046600) negative regulation of organelle assembly(GO:1902116) |
| 0.0 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 1.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.3 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.0 | 0.2 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 | 0.5 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
| 0.0 | 0.1 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.0 | 0.1 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.0 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 | 0.5 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
| 0.0 | 2.1 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.0 | 0.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.1 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.0 | 0.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.0 | 0.4 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.0 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.0 | 0.1 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.0 | 0.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
| 0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 | 0.2 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
| 0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.0 | 2.6 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.1 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
| 0.0 | 1.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.0 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 | 0.1 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.0 | 0.1 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.0 | 0.0 | GO:0001910 | regulation of leukocyte mediated cytotoxicity(GO:0001910) |
| 0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.0 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.0 | 0.1 | GO:0001775 | cell activation(GO:0001775) |
| 0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.1 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.1 | GO:0051685 | maintenance of ER location(GO:0051685) |
| 0.0 | 0.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 | 1.5 | GO:0031016 | pancreas development(GO:0031016) |
| 0.0 | 0.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.0 | 0.7 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 | 0.0 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 | 2.6 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 | 3.0 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 | 0.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.0 | 0.2 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
| 0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.0 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 | 0.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 | 0.2 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 | 0.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 1.3 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
| 0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.0 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.0 | 0.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.0 | 0.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 | 0.0 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.0 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 | 0.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
| 0.0 | 0.2 | GO:0010043 | response to zinc ion(GO:0010043) |
| 0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.1 | GO:0090034 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.0 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.0 | 0.1 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 | 0.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.0 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.2 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.1 | GO:0042113 | B cell activation(GO:0042113) |
| 0.0 | 0.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 | 0.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.0 | 0.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.0 | 0.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.0 | 0.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 | 0.2 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.0 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.0 | 0.2 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.0 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.0 | 0.1 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 | 0.0 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.0 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
| 0.0 | 0.2 | GO:0015867 | ATP transport(GO:0015867) adenine nucleotide transport(GO:0051503) |
| 0.0 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 | 0.1 | GO:1904377 | positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 | 0.0 | GO:0036230 | granulocyte activation(GO:0036230) |
| 0.0 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 0.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.0 | 0.1 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.0 | 0.0 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.0 | 0.1 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 0.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.1 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.0 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.0 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.0 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.0 | 0.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 | 0.0 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.0 | 0.1 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.3 | 234.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 2.5 | 27.7 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 1.9 | 5.8 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 1.6 | 21.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.6 | 11.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 1.5 | 10.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 1.5 | 35.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.4 | 4.3 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 1.4 | 10.0 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.4 | 4.3 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.3 | 2.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 1.1 | 4.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.1 | 1.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.9 | 8.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.8 | 4.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.8 | 3.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.8 | 16.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.8 | 6.0 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.7 | 13.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.7 | 2.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.7 | 2.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.6 | 2.4 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.6 | 3.0 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.6 | 0.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.6 | 1.7 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.5 | 2.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.5 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.5 | 105.6 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.5 | 6.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.5 | 2.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.4 | 3.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.4 | 3.4 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.4 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.4 | 1.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.4 | 2.1 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.4 | 1.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.4 | 2.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.4 | 23.9 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.4 | 1.5 | GO:0031523 | Myb complex(GO:0031523) |
| 0.4 | 7.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.4 | 11.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.4 | 2.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.4 | 1.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.4 | 2.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.4 | 1.1 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.3 | 1.7 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.3 | 1.0 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.3 | 2.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 5.9 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 35.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.3 | 1.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 1.7 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.3 | 0.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.3 | 0.8 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.3 | 96.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.3 | 21.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.3 | 1.9 | GO:0098536 | deuterosome(GO:0098536) |
| 0.3 | 1.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.3 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
| 0.3 | 2.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 1.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.3 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.3 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 2.5 | GO:0097413 | Lewy body(GO:0097413) |
| 0.2 | 0.5 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.2 | 5.2 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.2 | 1.6 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 0.7 | GO:0035101 | FACT complex(GO:0035101) |
| 0.2 | 2.6 | GO:0016589 | NURF complex(GO:0016589) |
| 0.2 | 1.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.2 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.2 | 6.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 22.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 3.7 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 2.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 1.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.2 | 4.8 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 0.8 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.2 | 5.3 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 1.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.2 | 1.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 0.6 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 0.6 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.2 | 1.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.2 | 15.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 1.5 | GO:0042611 | MHC protein complex(GO:0042611) |
| 0.2 | 0.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.2 | 0.9 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.2 | 3.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 1.2 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.2 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
| 0.2 | 1.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 2.2 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.2 | 3.2 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.2 | 13.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 1.8 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.2 | 5.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.2 | 1.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 8.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.2 | 2.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 33.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 0.7 | GO:0071944 | cell periphery(GO:0071944) |
| 0.1 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 3.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 1.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 2.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 17.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 1.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 1.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 1.5 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 2.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 0.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.1 | 0.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.1 | 0.7 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.1 | 0.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 1.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 6.6 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 0.9 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 0.4 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 0.7 | GO:1990462 | omegasome(GO:1990462) |
| 0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 2.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 2.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 1.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 1.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 1.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.1 | 3.8 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.1 | 1.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 1.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 1.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.3 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 1.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 1.4 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.1 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 0.8 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 7.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 0.4 | GO:0070701 | mucus layer(GO:0070701) |
| 0.1 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.5 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.4 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.1 | 1.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 3.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 2.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 11.2 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 1.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 0.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.1 | 1.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 1.2 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 121.5 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 2.2 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 1.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.1 | 0.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.6 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 7.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 3.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 1.2 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 4.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.1 | 8.7 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 1.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 2.3 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.0 | 0.2 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.0 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.5 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.0 | 0.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.0 | 3.0 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 0.9 | GO:0036019 | endolysosome(GO:0036019) |
| 0.0 | 1.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
| 0.0 | 1.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.0 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.4 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.0 | 0.4 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.0 | 1.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.0 | 1.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.0 | 0.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.0 | 0.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.0 | 1.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 2.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.0 | 2.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.0 | 2.4 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.0 | 3.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 4.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 3.5 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
| 0.0 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.0 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 0.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 2.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.0 | 1.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.0 | 0.8 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 0.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.0 | 4.1 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 3.0 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 1.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.0 | 1.9 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 1.8 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.0 | 0.3 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.0 | 2.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.0 | 0.1 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 4.0 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.0 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.0 | 0.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.0 | 0.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 21.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 3.6 | 236.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 3.0 | 8.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.6 | 10.3 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 2.3 | 27.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 2.1 | 450.8 | GO:0003823 | antigen binding(GO:0003823) |
| 2.0 | 5.9 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 1.7 | 8.6 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 1.6 | 6.6 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 1.6 | 7.9 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 1.5 | 6.0 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 1.4 | 4.2 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 1.3 | 4.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 1.3 | 3.8 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 1.3 | 3.8 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
| 1.3 | 5.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 1.2 | 14.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.2 | 4.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 1.2 | 8.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.2 | 5.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 1.1 | 18.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 1.1 | 6.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 1.1 | 3.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 1.0 | 3.0 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 1.0 | 4.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 1.0 | 2.9 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.0 | 2.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.9 | 2.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.9 | 4.6 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.9 | 13.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.9 | 10.5 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.9 | 34.1 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.8 | 4.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.8 | 13.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.8 | 3.3 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.8 | 2.5 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.8 | 2.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.8 | 4.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.8 | 4.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.8 | 3.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.8 | 4.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.7 | 2.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.7 | 2.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.7 | 4.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.7 | 1.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.7 | 7.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.7 | 13.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.7 | 2.7 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.7 | 2.0 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.7 | 4.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.7 | 1.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.7 | 0.7 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.6 | 2.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.6 | 1.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.6 | 1.9 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.6 | 9.8 | GO:0019864 | IgG binding(GO:0019864) |
| 0.6 | 5.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.6 | 4.7 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.6 | 1.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.6 | 5.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.6 | 24.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.6 | 1.7 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.6 | 1.7 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.6 | 8.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.5 | 4.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.5 | 2.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.5 | 10.0 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.5 | 2.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.5 | 3.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.5 | 3.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.5 | 2.1 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.5 | 4.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.5 | 2.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.5 | 0.5 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.5 | 26.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.5 | 0.5 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.5 | 2.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.5 | 1.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.5 | 1.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.5 | 1.9 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.5 | 5.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.5 | 1.4 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.4 | 5.8 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.4 | 1.8 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.4 | 0.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.4 | 2.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.4 | 1.7 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.4 | 2.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.4 | 14.6 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.4 | 3.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.4 | 1.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.4 | 1.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.4 | 8.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.4 | 3.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.4 | 14.1 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.4 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 40.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.4 | 3.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.4 | 1.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.4 | 1.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.4 | 5.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.4 | 6.7 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.4 | 10.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.4 | 2.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.4 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.4 | 3.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.4 | 1.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.4 | 0.7 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.4 | 1.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.4 | 1.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.4 | 1.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.4 | 4.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.4 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 2.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.4 | 1.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.4 | 0.4 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.4 | 1.8 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.4 | 2.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.4 | 1.8 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.4 | 4.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.3 | 1.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.3 | 0.7 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.3 | 1.4 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.3 | 2.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 2.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 1.0 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.3 | 0.7 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.3 | 1.3 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.3 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 15.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.3 | 1.6 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.3 | 0.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.3 | 1.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.3 | 2.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.3 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 1.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.3 | 2.4 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 2.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.3 | 7.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.3 | 7.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.3 | 2.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.3 | 4.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.3 | 0.9 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.3 | 3.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.3 | 0.9 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.3 | 1.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 2.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.3 | 1.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.3 | 3.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.3 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.3 | 9.3 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.3 | 1.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.3 | 0.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.3 | 0.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.3 | 1.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.3 | 0.8 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.3 | 1.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.3 | 3.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.3 | 1.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.3 | 1.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.3 | 2.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 1.0 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.3 | 1.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.3 | 0.8 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.3 | 1.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.3 | 1.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.3 | 1.3 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.2 | 5.5 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.2 | 0.7 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.2 | 3.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.2 | 1.5 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.2 | 5.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 31.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.5 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.2 | 1.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 2.6 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.2 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.2 | 0.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.2 | 3.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.2 | 1.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 1.2 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.2 | 1.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.2 | 0.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 0.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.2 | 0.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.2 | 1.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.2 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 0.2 | 1.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.2 | 0.7 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.2 | 0.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.2 | 4.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 0.6 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
| 0.2 | 1.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.2 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 2.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 2.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.2 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 1.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 0.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.8 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.2 | 1.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.2 | 0.6 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.2 | 1.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.2 | 3.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 2.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.2 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.2 | 1.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.2 | 0.6 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.2 | 8.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.6 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.2 | 0.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.2 | 2.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 6.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 0.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.2 | 3.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 1.6 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 1.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.2 | 2.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 0.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.2 | 1.2 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 0.2 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.2 | 0.5 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.2 | 2.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.2 | 1.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.2 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.2 | 1.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.2 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 0.5 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.2 | 0.5 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
| 0.2 | 5.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.2 | 2.8 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.2 | 0.5 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.2 | 0.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.1 | 0.4 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.1 | 0.4 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.1 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.1 | 0.6 | GO:0051380 | alpha-1B adrenergic receptor binding(GO:0031692) norepinephrine binding(GO:0051380) |
| 0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 1.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 4.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 4.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.1 | 0.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.1 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 1.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 3.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 3.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 2.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 3.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 5.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 1.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 1.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 3.4 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.1 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 1.7 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.6 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.1 | 1.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 4.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 3.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 4.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.1 | 0.6 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.1 | 0.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.1 | 0.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 5.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 3.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.1 | 0.4 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.1 | 0.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.1 | 1.6 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 0.1 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.1 | 0.4 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 6.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 1.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 3.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 1.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.5 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.3 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.1 | 0.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.1 | 2.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 1.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.8 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.1 | 0.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.1 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.1 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 0.4 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 0.9 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.4 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.1 | 0.3 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.1 | 0.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.1 | 1.4 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 1.8 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.1 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.1 | 0.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 3.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 2.5 | GO:0016208 | AMP binding(GO:0016208) |
| 0.1 | 1.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 2.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.3 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.1 | 0.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.1 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.1 | 1.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 1.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 0.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.1 | 0.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.1 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.1 | 1.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.1 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 1.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 2.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.9 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 1.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.1 | 4.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 1.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.1 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 0.5 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.1 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 1.7 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.1 | 0.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.1 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.1 | 2.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 2.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 4.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.4 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.1 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.1 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 1.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.1 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 1.7 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 2.2 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 1.5 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.1 | 0.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 1.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.1 | 0.3 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.1 | 0.3 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 0.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.1 | 0.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 3.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.5 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.1 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.1 | 3.2 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 1.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 0.2 | GO:0047017 | geranylgeranyl reductase activity(GO:0045550) prostaglandin-F synthase activity(GO:0047017) |
| 0.1 | 0.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.1 | 4.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 2.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
| 0.1 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 1.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.1 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 1.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.1 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 2.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.1 | 4.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 1.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.1 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.1 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 1.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.5 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 0.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 1.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 6.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 3.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 3.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.1 | 1.9 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 0.2 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.3 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 1.2 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.2 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.1 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 1.3 | GO:0001614 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 1.7 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
| 0.0 | 10.0 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 1.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.1 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 1.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 2.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.0 | 0.0 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.0 | 0.2 | GO:0022892 | substrate-specific transporter activity(GO:0022892) |
| 0.0 | 0.1 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.0 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.0 | 0.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 0.8 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.0 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.0 | 8.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.0 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.0 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.0 | 0.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.0 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.0 | 0.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.0 | 0.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.0 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.0 | 3.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.3 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.0 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.1 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.0 | 0.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.0 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
| 0.0 | 0.7 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.0 | 1.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.0 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.0 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.0 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.0 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.0 | 0.1 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
| 0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.0 | 0.2 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.0 | 2.2 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
| 0.0 | 0.1 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.0 | 1.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.0 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 0.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.0 | 0.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 1.4 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.0 | 1.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.0 | 0.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.0 | 0.1 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.0 | 0.2 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.0 | 0.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.0 | 0.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.0 | 0.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.0 | 0.6 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.0 | 0.1 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
| 0.0 | 0.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.2 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
| 0.0 | 0.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.0 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.0 | 0.1 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 4.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.0 | 6.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.0 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.0 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.0 | 0.0 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.1 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.0 | 1.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.0 | 0.5 | GO:0033558 | protein deacetylase activity(GO:0033558) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.0 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 34.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.7 | 50.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.7 | 72.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.7 | 9.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.7 | 25.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.6 | 9.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.4 | 5.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.4 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.4 | 4.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 4.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.4 | 19.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 22.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.3 | 5.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 13.3 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.3 | 15.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.3 | 7.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.3 | 18.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.3 | 8.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.3 | 8.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 8.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.3 | 9.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.3 | 9.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.3 | 4.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 14.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 4.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 8.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 20.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.2 | 1.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 4.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.2 | 3.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 8.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 5.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.2 | 9.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 3.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.2 | 5.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 4.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 3.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 4.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 6.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 2.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 3.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 3.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 10.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 6.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 1.4 | PID EPO PATHWAY | EPO signaling pathway |
| 0.1 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 7.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 5.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 5.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 2.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 2.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 6.5 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.1 | 1.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 5.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 3.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 2.3 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 1.3 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 4.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 18.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 1.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 1.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 1.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 3.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 1.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 11.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.1 | 23.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 1.1 | 26.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.8 | 93.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.8 | 10.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.7 | 8.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.7 | 0.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.7 | 47.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.7 | 13.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.6 | 11.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.6 | 5.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.5 | 18.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.5 | 18.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.5 | 1.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.4 | 19.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.4 | 4.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.4 | 34.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.4 | 25.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.4 | 10.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.4 | 12.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.4 | 10.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.3 | 9.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.3 | 11.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 3.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.3 | 3.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.3 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.3 | 8.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 1.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.3 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.3 | 9.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 0.3 | 4.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 4.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 4.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 4.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 6.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 5.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 3.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.2 | 7.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.2 | 5.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 3.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 4.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 4.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.2 | 5.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 6.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 0.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.2 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.2 | 5.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.2 | 4.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.2 | 2.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.2 | 1.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 10.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 3.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 1.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 3.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 5.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 7.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 2.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 2.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 1.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 3.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 12.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 4.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 5.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 1.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 1.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 11.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 18.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 2.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 4.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 2.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 9.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 13.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.1 | 4.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 3.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 3.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 3.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 2.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 0.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 3.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 1.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 5.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 3.7 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.1 | 3.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 4.4 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
| 0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 4.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 3.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 1.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 3.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 3.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 4.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 1.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 1.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.1 | 1.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 1.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 5.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 1.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 1.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 9.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 1.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 1.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.0 | 4.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.0 | 1.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.0 | 1.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.0 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 1.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 0.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.0 | 1.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 2.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 4.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 2.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |